Additional Information

Description

Exparel 1.3% 20mL is a long-acting local anesthetic containing bupivacaine encapsulated in a liposomal formulation. This formulation provides extended pain relief following surgical procedures, particularly in orthopedic, plastic, and abdominal surgeries. The encapsulated bupivacaine is released gradually, ensuring prolonged analgesic effects that can last up to 72 hours after administration, which helps reduce the need for opioid pain medications.

Exparel is typically administered via a single injection at the surgical site, allowing for targeted pain relief directly at the source of the discomfort. The liposomal technology used in Exparel allows for a controlled release of the drug over an extended period, which reduces the peak concentration and potential side effects compared to traditional bupivacaine formulations.

Exparel is suitable for use in adults undergoing various types of surgeries. It is particularly useful for patients with a high risk of opioid dependence, as it helps reduce opioid consumption by providing effective pain management without the need for systemic drugs. Careful administration and monitoring are essential to ensure patient safety and avoid overdose or adverse reactions.